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The withdrawal of the Liverpool Care Pathway 
in the United Kingdom: what are the implications 
for Australia?
A lack of evidence means that the benefi ts and harms of 
end-of-life care pathways remain poorly understood
I
ntegrated care pathways are documents that outline 
the essential steps of multidisciplinary care in dealing 
with a specifi c clinical problem.1 They can be used to 
introduce best clinical practice, to ensure that the most 
appropriate management occurs at the most appropriate 
time, and that it is provided by the most appropriate 
health professional. By providing clear instructions, 
decision support and a framework for clinician–patient 
interactions, care pathways guide the systematic 
provision of best evidence-based care. The Liverpool 
Care Pathway for the Dying Patient (LCP) is an example 
of an integrated care pathway — it was designed in the 
United Kingdom in the 1990s to guide care for people 
with cancer who were in their last days of life and 
expected to die in hospital.2,3 This pathway evolved 
out of a recognised local need to better support non-
specialist palliative care providers to care for patients 
dying of cancer in their inpatient units. Historically, 
despite the many people in acute care settings whose 
treatment intent was palliative,4 dying patients in 
these settings tended to receive insuffi cient attention 
from senior medical and nursing staff.5 As the quality 
of end-of-life care was considered inadequate, much 
could be learned from the way patients were cared for 
by palliative care services.5 The LCP was a strategy to 
improve this end-of-life care and was based on the care 
received by those dying in the palliative care setting.2,3
The LCP defi nes 18 goals of care for patients in the 
last 2 days of life. A range of care standards relating to 
comfort, psychological and insight concerns, religious 
and spiritual support, communication with family and 
others, communication with the primary health care 
team, and care after death are detailed in the LCP.2,3 
The LCP outlines clear procedures and guidance for 
the multidisciplinary team to approach care. Over the 
past decade, the rapid diffusion of the LCP, from being 
a local solution to being implemented widely, has been 
phenomenal. This expansion has occurred in the absence 
of robust evaluation. In the UK, the LCP was actively 
promoted by the National Health Service and was 
adopted as standard practice by more than 1800 health 
care institutions,6 with evidence of its use extending to 
other parts of the world.7 Across Australia, several end-
of-life care pathways (EOLCPs) have been adapted from 
the LCP. Although there are no existing data indicating 
a precise number of institutions using them, it is clear 
that there has been widespread uptake of EOLCPs in 
Australian acute care hospitals and residential aged care 
facilities (RACFs).8-15 Perhaps based on this widespread 
adoption, the National Palliative Care Strategy 20109 
identifi ed the need to support a national roll-out of an 
integrated EOLCP across all care sectors (primary, acute 
and aged care).
In 2013, in response to substantial concerns raised 
by the public and by health professionals, the UK 
government commissioned an independent review 
of the LCP, led by Baroness Julia Neuberger.16 The 
panel reviewed multiple sources, including written 
submissions from the public and health professionals 
with experience of the LCP, the academic literature and 
hospital complaints. Based on the evidence provided, 
the panel determined that the implementation of 
the LCP was often associated with poor care.16 Its 
report highlighted the complexity around the use of 
the pathway, specifi cally highlighting ethical, safety, 
clinical practice and legal problems, and how poorly 
dying is diagnosed in clinical care.16 Although the 
intention and end-of-life care principles underpinning 
the LCP are sound, use of the pathway has extended 
well beyond the evidence base and despite the lack of 
any rigorous, prospective evaluation at the time of its 
widespread uptake.6,7 Further, it was emphasised in 
the report that the LCP cannot and should not replace 
good clinical practice encompassing empathy, humanity 
and communication. As a result of the review, the UK 
government decided to phase out the LCP nationally 
over the following 6–12 months.17
A recent update of our Cochrane systematic review6 
identifi ed four Australian studies (one audit12 and three 
pretest–post-test studies13-15) evaluating EOLCPs, 
all of which had been adapted from the LCP. The 
retrospective audit of 160 hospital inpatients reported 
potential benefi ts of an EOLCP in documenting 
clinician assessments of goals of care as designed by 
the pathway.12 A pilot study of 35 general medical 
patients reported potential benefi ts in documentation, 
medication orders and other aspects of care.13 Another 
study demonstrated that, after the implementation of 
an EOLCP for residents of six RACFs, a signifi cantly 
lower proportion of those who were commenced on 
the EOLCP transferred to hospital at the end of life 
(2/118) compared with those who were not commenced 
on the EOLCP (29/135).15 The following year, another 
pretest–post-test study (involving 600 RACF residents 
before implementation of an EOLCP, and 594 after 
implementation) did not fi nd any statistically signifi cant 
differences in the number of deaths in RACFs, deaths in 
hospitals or transfers to hospitals.14
Despite the widespread adoption and policy 
endorsement of EOLCPs, there has been insuffi cient 
rigorous evaluation of the net effect in Australia 
the LCP cannot 
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or internationally. The benefi ts and harms of such 
pathways, whether intended or unintended, remain 
poorly understood.6,7 The only randomised controlled 
trial to date, conducted with Italian cancer patients, did 
not fi nd any signifi cant benefi ts for improving patient 
outcomes.18 The lack of high-quality health services 
research before widespread implementation of the LCP 
in the UK and other countries has created a dilemma for 
Australia: do the adverse fi ndings from the Neuberger 
review16 apply to Australia and, if so, to what extent? If 
not, how certain are we? What are the implications of 
these fi ndings for our National Palliative Care Strategy? 
And how should the Strategy’s recommended action to 
support the national roll-out of an EOLCP be managed? 
Rigorous studies should be designed to establish 
whether the outcomes for dying patients who are placed 
on an EOLCP are different to those for patients receiving 
usual care and, if so, to answer several key questions:
 ● Are the right people put on an EOLCP at the right 
time in their illness trajectory?
 ● In which settings should an EOLCP be used?
 ● Who should have the authority to initiate an 
EOLCP?
 ● What specific medical history is required before 
initiating an EOLCP?
 ● How senior should the clinicians be and how much 
of the patient’s history should they know before 
initiating an EOLCP?
 ● Are there any differences in outcomes when 
comparing different EOLCPs?
There remains an urgent need for large Phase III 
studies thoroughly measuring these outcomes in 
Australia, and subsequent monitoring of the outcomes 
if widespread uptake is supported by well designed, 
well conducted studies.19 The conduct of such studies 
can be complex and expensive. The National Health and 
Medical Research Council (NHMRC) and other funding 
bodies should support research teams that consist of 
experienced palliative care researchers and clinicians, 
and an economist. Process and cost-effectiveness 
outcomes must not be ignored in any future research 
of EOLCPs. To ensure generalisability, studies should 
stratify participants according to different care settings, 
including general acute care, emergency departments, 
cancer care units, RACFs and specialist palliative 
care units. Were such studies to produce positive 
results, careful ongoing evaluation of the outcomes 
of implementing any revised pathway as it is broadly 
introduced would be imperative.
While we wait for results from future prospective 
randomised evaluations, we recommend that the next 
sensible step for Australia is to contextually review each 
of the shortfalls or potential adverse effects of the LCP 
highlighted by the Neuberger review.16 Subsequently, 
actions to avoid these unwanted consequences could 
be assessed. Importantly, the Neuberger review 
identifi ed that clinicians need to actively diagnose 
that a person is dying, and that no obvious reversible 
or precipitous changes have been overlooked. Once 
established, the diagnosis needs to be compassionately 
but clearly communicated to the patient and his or her 
family. An evidence-based clinical practice guideline 
on communicating prognosis and end-of-life issues to 
patients with advanced disease and their caregivers 
has been published.20 It provides health professionals 
with useful and unambiguous guidance about their role 
in acknowledging the uncertainty and unreliability of 
prognostic predictions and the diffi culty this creates for 
patients or caregivers. Failure to communicate clearly 
was one of the most serious concerns expressed in the 
Neuberger review.
Australia needs to respond to these concerns that 
have been so carefully documented at a time when 
end-of-life awareness continues to rise. There is no 
room for complacency. Rather than pursuing an end-
of-life care strategy based on limited evidence, we 
urge policymakers to continue to invest in building the 
palliative care capabilities of the Australian health care 
workforce, extending the reach of specialist palliative 
care services and building the palliative care evidence 
base through investing in rigorous research. Ultimately, 
if the LCP is to be replaced, there needs to be systematic 
measurement of the benefi ts and harms generated by 
such a process. No intervention is without problems, and 
as a new process is implemented, the unexpected harms 
it may generate need to be measured so they can be 
overcome as they arise.
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